Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Purina Institute to share cardiology nutrition research
Dr Libby Sheridan, Purina's scientific affairs manager
The Institute will share updates on MMVD in free CPD symposium.

The Purina Institute will share the latest updates on the diagnosis and management of myxomatous mitral valve disease (MMVD) in a free symposium on Wednesday June 23.

In the symposium participants will be offered valuable clinical insights and be presented with ground-breaking new research on the role of nutrition in helping to support the ailing heart. The event will run from 6pm to 7.25pm on Wednesday June 23, and will count for 1.5 hours of CPD. 

The symposium will include globally recognised speakers, including Dr John Bonagura, specialist in cardiology and internal medicine, who will share his knowledge on the diagnosis and management of MMVD in dogs. 

Dr Bonagura's talk will cover highly clinically relevant topics, including how to relate disease pathology to the findings on cardiac auscultation, and also how to establish management approaches for the different stages of MMVD.

Following the presentation from Dr Bonagura, participants will the hear from world-class specialist in nutrition and independent consultant Dr Dottie Laflamme. Dr Laflamme's talk will provide insights on nutritional management in canine heart disease and explain how the latest research indicates that key nutrients can slow the progression of MMVD in its early stages. 

These latest insights into the role of nutrition are based on cutting-edge metabolomics research conducted by Purina scientists. This research and subsequent clinical data will be discussed by Dr Laflamme, and participants will learn how dietary modification could form part of a comprehensive  management plan for MMVD patients. There will also be a chance to ask questions in a live Q&A following the talks. 

Dr Libby Sheridan, Purina scientific affairs manager for the UK and Ireland, said: “MMVD is seen very commonly in practice, so this topic is really relevant for vets and nurses.

“Traditionally dietary support for heart disease has centred on sodium restriction. This latest research is very exciting as it opens up possibilities for dietary support on a much more comprehensive scale. We’re delighted to offer this free symposium to help professionals keep up to date with the latest advances so they can provide the best possible care.” 

The symposium will run live from 6pm to 7.25pm on Wednesday June 23, and the full agenda and attendance is available here: purinainstitute.com/events 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.